(3,4,5-trihydroxyoxan-2-yl) 3,4-dihydroxybenzoate

Metabolite details

Identifier

VWQASRWQZBVNEI-UHFFFAOYSA-N

InChI Key

VWQASRWQZBVNEI-UHFFFAOYSA-N

IUPAC name

(3,4,5-trihydroxyoxan-2-yl) 3,4-dihydroxybenzoate

Preferred name

(3,4,5-trihydroxyoxan-2-yl) 3,4-dihydroxybenzoate

INN name

—

Synonym

—

ChEBI

CHEBI:190901

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h